Medical Devices: Page 169
-
Mayo, Arizona State team up to found medtech startup accelerator
The six-month program is designed to connect startups with investors and physicians.
By Nick Paul Taylor • Jan. 17, 2019 -
Top House Democrat to focus on diagnostics revamp, drug prices in 2019
With Democrats now in power, the new chair of a key oversight subcommittee laid out her priorities, including proposals she argues will bolster the Affordable Care Act.
By David Lim • Jan. 17, 2019 -
Explore the Trendline➔
Sara Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
FDA clears energy tools for TransEnterix robotic surgery system
The company has received FDA 510(k) clearance for a set of advanced energy instruments that can be used with its Senhance robotic surgical system.
By Susan Kelly • Jan. 16, 2019 -
Medtronic links patients’ pacemakers with their smartphones
The MyCareLink Heart mobile app is compatible with the company’s BlueSync technology-enabled pacemakers and eliminates the need for other remote monitoring hardware.
By Susan Kelly • Jan. 16, 2019 -
Medtech therapeutic areas to track in 2019
Cardiovascular health, diabetes and oncology diagnostics are among the products with greatest consumer and investor interest.
By Maria Rachal • Jan. 15, 2019 -
Abbott heart device for premature babies wins FDA approval
The device for sealing a hole in the heart of premature infants is smaller than a pea and can treat newborns weighing as little as 2 pounds.
By Susan Kelly • Jan. 15, 2019 -
Edwards Lifesciences pays Boston Scientific $180M to settle multiple patent disputes
Edwards will make a one-time payment to Boston and the companies will drop all other patent suits and appeals related to their current portfolios of heart technologies.
By Maria Rachal • Updated Jan. 15, 2019 -
FDA clears absorbable foot and ankle implant
Ossio said its bioabsorbable orthopaedic fixation implant for foot and ankle conditions, made from a mineral fiber matrix, integrates into the surrounding anatomy in 18 to 24 months.
By Susan Kelly • Jan. 15, 2019 -
Wound therapy device wins FDA authorization
The product eliminates the need to use gauze or foam when applying negative pressure to wounds.
By Nick Paul Taylor • Jan. 15, 2019 -
Jefferies predicts upbeat 2019 medtech outlook
As the new year gets underway, the investment bank identifies growth catalysts for eight medtechs.
By Susan Kelly • Jan. 14, 2019 -
Mobile and wearable data increasingly useful to patients, JAMA authors say
Advances in internet-connected consumer devices and personal EHRs mean the systems may finally be poised to to improve patient outcomes, according to recent physician opinions published in JAMA.
By Susan Kelly • Jan. 14, 2019 -
Senate Democrats question Gottlieb on FDA shutdown impact
FDA Commissioner Scott Gottlieb wrote Tuesday on Twitter the agency has returned 100 inspection staff to work to oversee high-risk medical device facilities.
By David Lim • Updated Jan. 16, 2019 -
Jacob Bell/MedTech Dive
FDA grants breakthrough designation to wearable dialysis device
The portable, wearable peritoneal dialysis device by Singapore-based AWAK Technologies is intended for patients with end-stage renal disease as an alternative to long hours of connection to large dialysis machines.
By Susan Kelly • Jan. 14, 2019 -
Uncertainties abound with growing prospect of hard Brexit
The future for medtech companies in Europe was further complicated Tuesday with Britain’s government firmly rejecting PM Theresa May’s EU exit deal by a vote of 432 to 202, prompting debate of a no-confidence vote Wednesday.
By Meg Bryant • Updated Jan. 16, 2019 -
Brian Tucker/MedTech Dive
5 medtech trends to watch in 2019
FDA regulatory changes, diagnostics legislation, a sustained focus on cybersecurity, looming European Union regulations and China trade headwinds are likely to take center stage.
By David Lim • Jan. 11, 2019 -
FDA to beef up Sentinel postmarket electronic safety system
The agency announced a five-year plan to expand and strengthen the system by adding new data types, developing analytic methods and recruiting more collaborators to the network.
By Susan Kelly • Jan. 11, 2019 -
Empatica gets FDA clearance for epilepsy monitor in children
The device analyzes motion and physiological signals to detect when the wearer is having a seizure.
By Nick Paul Taylor • Jan. 11, 2019 -
Intuitive ends bumper 2018 with 19% growth in da Vinci procedures
The robotic surgery leader brushed off competition concerns to deliver another quarter of forecast-topping growth.
By Nick Paul Taylor • Jan. 10, 2019 -
FDA denies citizen petition calling for electroconvulsive therapy ban
The agency dismissed claims that the devices pose an unreasonable risk of injury.
By Nick Paul Taylor • Jan. 10, 2019 -
Grassley to zoom in on drug pricing, insurance mergers as Senate panel chair
The new Republican chairman of the Senate Finance Committee laid out his agenda for the year ahead.
By David Lim • Jan. 10, 2019 -
UK updates no-deal Brexit advice as vote on withdrawal agreement nears
Companies will need a designated individual based in the U.K. to register medical devices in the country.
By Nick Paul Taylor • Jan. 10, 2019 -
Retrieved from Apple on September 12, 2018
Medical records key to Apple health strategy: report
Establishing itself as the platform for consumers’ personal health records will be central to the tech giant’s app, services and wearables strategies, according to a new report from research firm CB Insights.
By Susan Kelly • Jan. 9, 2019 -
Medtronic recalls imaging software used in brain surgery
The systems are being recalled due to reports of inaccurate information displaying during biopsy procedures.
By Susan Kelly • Jan. 9, 2019 -
JPM19: FDA warns it won’t be long before user fee funding runs dry
With no end in sight to the government shutdown, Commissioner Scott Gottlieb said medical device user fee programs have about two to three months of funding left.
By Jacob Bell • Jan. 9, 2019 -
Boston Scientific, Medtronic give glimpse into 2019 at JPM
Boston Scientific’s stock ticked up after its J.P. Morgan Healthcare Conference presentation Tuesday, whereas Medtronic’s shares were down 6% Monday following conservative comments from company leadership.
By Maria Rachal • Jan. 9, 2019
Previous
